Csl Vifor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Csl vifor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Csl Vifor Today - Breaking & Trending Today

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Medicines Agency's (EMA) CHMP has recommended approval of sparsentan for the treatment of adults with primary IgAN with a urine protein excretion >1.0 g/day (or urine protein-to-creatinine ratio ≥0.75 g/g). IgAN is a rare kidney disorder and a leading cause of kidney failure. The CHMP opinion provides the basis for the European Commission's final decision regarding CMA for sparsentan. If approved in Europe ....

New Zealand , Emmanuelle Lecomte Brisset , Fresenius Medical Care , European Commission , Vifor International , Head Of Global Regulatory Affairs , Drug Administration , European Union , Senior Vice President , Global Regulatory Affairs , Travere Therapeutics , Marketing Authorization Application , Orphan Medicinal Product Designation , Vifor Fresenius Medical Care Renal Pharma , Iga Nephropathy , Csl Vifor , European Commission , Treatment Options , Kidney Failure , Kidney Disorder , European Medicines Agency , Treatment Option , Kidney Function , Urine Protein ,